69 related articles for article (PubMed ID: 12773770)
1. Gene expression patterns as potential molecular biomarkers for malignant transformation in human keratinocytes treated with MNNG, arsenic, or a metal mixture.
Bae DS; Handa RJ; Yang RS; Campain JA
Toxicol Sci; 2003 Jul; 74(1):32-42. PubMed ID: 12773770
[TBL] [Abstract][Full Text] [Related]
2. Glutathione-dependent reduction of arsenate in human erythrocytes--a process independent of purine nucleoside phosphorylase.
Németi B; Gregus Z
Toxicol Sci; 2004 Dec; 82(2):419-28. PubMed ID: 15470234
[TBL] [Abstract][Full Text] [Related]
3. Characterization of gene expression changes associated with MNNG, arsenic, or metal mixture treatment in human keratinocytes: application of cDNA microarray technology.
Bae DS; Hanneman WH; Yang RS; Campain JA
Environ Health Perspect; 2002 Dec; 110 Suppl 6(Suppl 6):931-41. PubMed ID: 12634122
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of genes associated with cell proliferation and apoptosis induced by okadaic acid during the transformation process of BALB/c 3T3 cells.
Ao L; Liu JY; Gao LH; Liu SX; Yang MS; Huang MH; Cao J
Toxicol In Vitro; 2008 Feb; 22(1):116-27. PubMed ID: 17935941
[TBL] [Abstract][Full Text] [Related]
5. Gene expression changes associated with altered growth and differentiation in benzo[a]pyrene or arsenic exposed normal human epidermal keratinocytes.
Perez DS; Handa RJ; Yang RS; Campain JA
J Appl Toxicol; 2008 May; 28(4):491-508. PubMed ID: 17879257
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols.
Gregus Z; Roos G; Geerlings P; Németi B
Toxicol Sci; 2009 Aug; 110(2):282-92. PubMed ID: 19478237
[TBL] [Abstract][Full Text] [Related]
7. Identification of early responsive genes in human amnion epithelial FL cells induced by N-methyl-N'-nitro-N-nitrosoguanidine using oligonucleotide microarray and quantitative real-time RT-PCR approaches.
Li H; Shao J; Lu X; Gao Z; Yu Y
Mutat Res; 2008 Sep; 644(1-2):1-10. PubMed ID: 18644392
[TBL] [Abstract][Full Text] [Related]
8. New catalytic mechanism for human purine nucleoside phosphorylase.
Canduri F; Fadel V; Basso LA; Palma MS; Santos DS; de Azevedo WF
Biochem Biophys Res Commun; 2005 Feb; 327(3):646-9. PubMed ID: 15649395
[TBL] [Abstract][Full Text] [Related]
9. [Tight binding transition state analogues of purine nucleoside phosphorylase--meaning, design and properties].
Lewandowicz A
Postepy Biochem; 2004; 50(3):218-27. PubMed ID: 15822751
[No Abstract] [Full Text] [Related]
10. Biological activity of inorganic arsenic and antimony reflects oxidation state in cultured human keratinocytes.
Patterson TJ; Ngo M; Aronov PA; Reznikova TV; Green PG; Rice RH
Chem Res Toxicol; 2003 Dec; 16(12):1624-31. PubMed ID: 14680377
[TBL] [Abstract][Full Text] [Related]
11. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
Gregus Z; Németi B
Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424
[TBL] [Abstract][Full Text] [Related]
12. Persistence of gene expression changes in stomach mucosae induced by short-term N-methyl-N'-nitro-N-nitrosoguanidine treatment and their presence in stomach cancers.
Yamashita S; Nomoto T; Abe M; Tatematsu M; Sugimura T; Ushijima T
Mutat Res; 2004 May; 549(1-2):185-93. PubMed ID: 15120970
[TBL] [Abstract][Full Text] [Related]
13. Rat hepatocytes with elevated metallothionein expression are resistant to N-methyl-N'-nitro-N-nitrosoguanidine cytotoxicity.
Moffatt P; Plaa GL; Denizeau F
Toxicol Appl Pharmacol; 1996 Jan; 136(1):200-7. PubMed ID: 8560476
[TBL] [Abstract][Full Text] [Related]
14. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
Miles RW; Tyler PC; Furneaux RH; Bagdassarian CK; Schramm VL
Biochemistry; 1998 Jun; 37(24):8615-21. PubMed ID: 9628722
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of analogs of forodesine HCl, a human purine nucleoside phosphorylase inhibitor-Part I.
Kamath VP; Xue J; Juarez-Brambila JJ; Morris CB; Ganorkar R; Morris PE
Bioorg Med Chem Lett; 2009 May; 19(10):2624-6. PubMed ID: 19386498
[TBL] [Abstract][Full Text] [Related]
16. Effects of arsenic, cadmium, chromium, and lead on gene expression regulated by a battery of 13 different promoters in recombinant HepG2 cells.
Tully DB; Collins BJ; Overstreet JD; Smith CS; Dinse GE; Mumtaz MM; Chapin RE
Toxicol Appl Pharmacol; 2000 Oct; 168(2):79-90. PubMed ID: 11032763
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of analogs of forodesine HCl, a human purine nucleoside phosphorylase inhibitor-Part II.
Kamath VP; Xue J; Juarez-Brambila JJ
Bioorg Med Chem Lett; 2009 May; 19(10):2627-9. PubMed ID: 19386496
[TBL] [Abstract][Full Text] [Related]
18. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
19. Arsenate reduction in human erythrocytes and rats--testing the role of purine nucleoside phosphorylase.
Nemeti B; Csanaky I; Gregus Z
Toxicol Sci; 2003 Jul; 74(1):22-31. PubMed ID: 12730608
[TBL] [Abstract][Full Text] [Related]
20. Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts.
Biedermann KA; Landolph JR
Cancer Res; 1987 Jul; 47(14):3815-23. PubMed ID: 3594439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
